Study demonstrates ability to remove key barrier to an HIV cure

The results of a novel study presented by Emory researchers during the International AIDS Society (IAS) Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure. The study, led by Monica Reece, a Ph.D. candidate in Emory’s Microbiology and Genetics Program, and directed by Christina Gavegnano, Ph.D., demonstrates the potential of Jak inhibitors, specifically ruxolitinib, to significantly decay the viral reservoir in people with HIV, offering a novel pathway toward long-term remission or a cure.

WELL DONE CHILANGA

IT is a relief that councils have suddenly sprung to life and carrying out work that they should have been doing that led to a deterioration in maintaining standards in their localities.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.